Recent Updates
Recently added Catalysts
ANIP

About ANI ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product dev

Key Takeaway: Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers), hormone

Full Press Release Details

Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic
prescription pharmaceuticals. The Company's targeted areas of product development currently include narcotics, oncolytics (anti-cancers),
hormones and steroids, and complex formulations involving extended release and combination products. For more information, please
visit our website www.anipharmaceuticals.com.
the extent any statements made in this release deal with information that is not historical, these are forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, those
relating to the development, manufacturing and commercialization of the product and any additional product launches from the Company's
generic pipeline, other statements that are not historical in nature, particularly those that utilize terminology such as "anticipates,"
"will," "expects," "plans," "potential," "future," "believes,"
"intends," "continue," other words of similar meaning, derivations of such words and the use of future
and risks may cause the Company's actual results to be materially different than those expressed in or implied by such forward-looking
statements. Uncertainties and risks include, but are not limited to, the risk that the Company may face with respect to importing
raw materials; competition from other products; acquisitions; contract manufacturing arrangements; delays or failure in obtaining
product approval from the U.S. Food and Drug Administration; general business and economic conditions; market trends; products
development; regulatory and other approvals and marketing.
More detailed information on these and additional factors that
could affect the Company's actual results are described in the Company's filings with the Securities and Exchange
Commission ("SEC"), including its most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well
as other filings with the SEC. All forward-looking statements in this news release speak only as of the date of this news release
and are based on the Company's current beliefs, assumptions, and expectations. The Company undertakes no obligation to update
or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Communications, Inc.
Last updated: Feb 17, 2021